# Simnova

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/simnova

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: simnovabio.com
- Total disclosed funding: $87M
- Latest round: Series B (Aug 31, 2026)
- Investors on record: 8

## About

Based in Shanghai, China and established in 2019, Shanghai Xianbo Biopharmaceutical Co., Ltd., dba Simnova, is a biotechnology company focusing on the development of cell therapy for cancer treatment. The company was affiliated to Simcere Group before spinning off to operate independently in 2021. In 2022, the company's first product of the allogeneic CAR-NK platform has entered clinical stage.

In August 2026, Simnova raised approximately CNY 400 million in Series B funding co-led by Fortera Capital, Cenova Ventures and Pudong Venture Capital with participation from Zhangjiang Science & Technology Venture Capital, Oriza Holdings and Youshan Capital.

Simnova focuses on CAR-based cell therapies (including CAR-NK and CAR-T) for cancer patients with hematologic malignancies or solid tumors. The company has developed multiple pipelines for the treatment of B-cell malignancies (SNC103), multiple myeloma (SNC112), solid tumors (SNC113, SNC115), etc. 

The company generates revenue from developing cell therapy for cancer treatment.

The company will primarily use the Series B funding to accelerate confirmatory clinical studies of the universal CAR-NK core pipeline SNC103 and to advance the in vivo CAR-T platform SNC116 into registration clinical development.

## Funding rounds

- Series B, Aug 31, 2026, $60M — Oriza Holdings, Cenova Ventures, Pudong Venture Capital, Youshan Capital, Fortera Capital, Zhangjiang Science & Technology Venture Capital
- Series A, Mar 11, 2024, $28M — Oriza Holdings, Triwise Capital, Youshan Capital, PagodaTree Partners

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A, Series B
- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Series A
- Youshan Capital (https://capitalatlas.ai/funds/youshan-capital) — Series A, Series B
- PagodaTree Partners (https://capitalatlas.ai/funds/pagodatree-partners) — Series A
- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series B
- Pudong Venture Capital (https://capitalatlas.ai/funds/pudong-venture-capital) — Series B
- Fortera Capital (https://capitalatlas.ai/funds/fortera-capital) — Series B
- Zhangjiang Science & Technology Venture Capital (https://capitalatlas.ai/funds/zhangjiang-science-technology-venture-capital) — Series B